Andhra Pradesh, India

Nagaraju Maddela

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Biophore India Pharmaceuticals Private Limited. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nagaraju Maddela. Retrieved from https://idiyas.com/inventor/nagaraju-maddela

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Nagaraju Maddela

Introduction

Nagaraju Maddela is a notable inventor based in Andhra Pradesh, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel processes for drug preparation. His work exemplifies the spirit of innovation and dedication to advancing medical science.

Latest Patents

Nagaraju Maddela holds a patent for a process titled "Process for the preparation of eletriptan." This invention relates to a novel process for the preparation of (R)-3-((1-methylpyrrolidin-2-yl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole and its intermediates. This patent highlights his expertise in pharmaceutical chemistry and his commitment to improving therapeutic options.

Career Highlights

Throughout his career, Nagaraju has worked with Biophore India Pharmaceuticals Private Limited and Biophore India Pharmaceuticals Pvt. Ltd. His experience in these companies has allowed him to hone his skills and contribute to various innovative projects in the pharmaceutical industry.

Collaborations

Nagaraju has collaborated with several professionals in his field, including Manik Reddy Pullagurla and Jagadeesh Babu Rangisetty. These collaborations have enriched his work and fostered a creative environment for innovation.

Conclusion

Nagaraju Maddela's contributions to the field of pharmaceuticals through his patent and collaborative efforts demonstrate his commitment to innovation. His work continues to inspire others in the industry, paving the way for future advancements in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…